• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


130.550 EUR 0.460 0.35%

As of 11:28:50 ET on 08/22/2014.

Snapshot for Illumina Inc (ILU)

Open: 128.260 Day's Range: 127.250 - 130.550 Volume: 160
Previous Close: 131.010 52wk Range: 54.600 - 136.590 1-Yr Rtn: +120.41%

Stock Chart for ILU

No chart data available.
  • ILU:GR 130.550
  • 1D
  • 1M
  • 1Y
Interactive ILU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILU

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 75.5125
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.2890
Est. PEG Ratio 3.4709
Market Cap (M EUR) 18,198.67
Shares Outstanding (M) 139.40
30 Day Average Volume 205
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILU

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil